trending Market Intelligence /marketintelligence/en/news-insights/trending/4B-VOSjtdJcKrO5ZZ6eWdA2 content esgSubNav
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us
In This List

Allena Pharmaceuticals plans $92M IPO

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

Allena Pharmaceuticals plans $92M IPO

Allena Pharmaceuticals Inc. plans to raise $92 million through an initial public offering of common stock.

The Newton, Mass.-based biotech company granted underwriters a 30-day option to buy additional common shares at the offering price.

According to its prospectus, Allena Pharmaceuticals applied to list the shares on the Nasdaq Global Market under the symbol ALNA.

Credit Suisse Securities (USA) LLC, Jefferies LLC, Cowen and Co. LLC and Wedbush Securities Inc. are acting as underwriters for the offering.